Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
05/01/2003 | CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
04/30/2003 | CN1414961A Substituted oximes and hydrazones as neurokinin antagonists |
04/30/2003 | CN1414952A Heterocyclic compounds having sulfonic acid |
04/30/2003 | CN1107059C Azole derivative |
04/29/2003 | US6555693 Compounds that affect the expression of genes essential for the proliferation of the pathogen; promoters or gene expression inhibition; binding to double-stranded DNA; fungicides; bactericides; viricides |
04/29/2003 | US6555569 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
04/29/2003 | US6555568 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester for example; treating angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus |
04/29/2003 | US6555565 Apoptosis inhibitor |
04/29/2003 | US6555563 Compounds based on 2-aryl-5-(imidazol-2-yl)-1,3,4-thiadiazole or the corresponding 1,3,4-oxadiazole; selective COX-2 (cyclooxygenase-2) inhibitors; side effect reduction |
04/29/2003 | US6555561 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
04/29/2003 | US6555555 Fused thiophone derivatives and drugs containing the same as the active ingredient |
04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
04/29/2003 | US6555535 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors |
04/29/2003 | US6555501 4-trifluoromethyl-3-oxazolylpyridines, processes for their preparation, compositions comprising them and their use as pesticides |
04/29/2003 | CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors |
04/24/2003 | WO2003033494A1 Benzimidazole derivative |
04/24/2003 | WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
04/24/2003 | WO2003033486A1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
04/24/2003 | WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
04/24/2003 | WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors |
04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
04/24/2003 | WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
04/24/2003 | WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
04/24/2003 | WO2003032916A2 Organosulfur inhibitors of tyrosine phosphatases |
04/24/2003 | WO2003032901A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
04/24/2003 | WO2003032731A1 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
04/24/2003 | WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis |
04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
04/24/2003 | US20030078438 N-heterocyclicamide compounds; used as anticoagulant agent |
04/24/2003 | US20030078430 Process for preparing 1,4-dihydropyridine compounds |
04/24/2003 | US20030078427 Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
04/24/2003 | US20030078426 Thiazolidine or oxazolidine compounds useful for preventing or therapeutical agents for various diseases such as diabetes and hyperlipemia |
04/24/2003 | US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
04/24/2003 | US20030078288 Indole derivatives |
04/24/2003 | US20030078287 For controlling plant and animal pests |
04/24/2003 | US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects |
04/24/2003 | US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor |
04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
04/24/2003 | US20030078271 Pyrimidine and indolone derivatives |
04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
04/24/2003 | US20030078261 Prostaglandin agonists |
04/24/2003 | US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
04/24/2003 | US20030078259 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
04/24/2003 | US20030078258 Adrenergic blocking agents |
04/24/2003 | US20030078256 Serotonin receptor antagonist; treating cardiovascular disorder |
04/24/2003 | US20030078252 Used to treat abnormal cell growth and central nervous system disorders |
04/24/2003 | US20030078251 Triglyceride and cholesterol lowering activity and treats hyperlipidemia |
04/24/2003 | US20030078193 Therapeutic Agents For Diabetes |
04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
04/24/2003 | CA2463906A1 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
04/24/2003 | CA2463724A1 Organosulfur inhibitors of tyrosine phosphatases |
04/24/2003 | CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
04/23/2003 | EP1304330A2 Polymorph of 5-[4-[2-(N-Methyl-N-(2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dione maleic acid salt |
04/23/2003 | EP1304327A2 Glutamine-thiazolidide and -pyrrolidide and their use as dipeptidylpeptidase IV inhibitors |
04/23/2003 | EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
04/23/2003 | EP1303514A1 Process for preparing azacycloalkanoylaminothiazoles |
04/23/2003 | EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
04/23/2003 | EP1303512A1 Process for preparing arylacetylaminothiazoles |
04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
04/23/2003 | EP1303508A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
04/23/2003 | EP1303506A1 6-heteroarylphenanthridines |
04/23/2003 | EP1303500A1 Heterocyclic fluoroalkenyl thioethers (ii) |
04/23/2003 | EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors |
04/23/2003 | EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
04/23/2003 | EP1303488A1 Piperidine compounds for use as ccr-3 inhibitors |
04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
04/23/2003 | EP1303273A1 New pharmaceutical composition and the process for its preparation |
04/23/2003 | EP1303272A2 Benzothiazole derivatives |
04/23/2003 | EP1133483B1 Il-5 inhibiting 6-azauracil derivatives |
04/23/2003 | EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives |
04/23/2003 | EP1086179B1 Energy transfer assay method and reagent |
04/23/2003 | EP1082314B1 New dipeptidyl peptidase iv effectors |
04/23/2003 | EP1077975B1 Water soluble azoles as broad-spectrum antifungals |
04/23/2003 | EP1028960B1 Process for the preparation of thiazolidinedione derivatives |
04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
04/23/2003 | EP0889881B1 New triazoles as therapeutic agents for fungal infections |
04/23/2003 | EP0844998B1 Halobenzimidazoles and their use as microbicides |
04/23/2003 | EP0787725B1 Quinoline derivative |
04/23/2003 | CN1413208A Novel derivatives of 3-imino-1,2,-dithioles, method for producing them and pharmaceutical compositions containing the same |
04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
04/23/2003 | CN1413200A Cyanomethylene compounds, process for producing the same, and agricultural or horticultural bactericide |
04/23/2003 | CN1413195A Immunoassay detection method for neonicotinyl insecticides |
04/23/2003 | CN1413105A Novel method of treatment |
04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
04/23/2003 | CN1106381C Preparation process of nitroguanidine derivatives |
04/23/2003 | CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus |
04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
04/22/2003 | US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
04/22/2003 | US6552077 Kidney disorders |
04/22/2003 | US6552067 EP4 receptor selective agonists in the treatment of osteoporosis |
04/22/2003 | US6552058 Oxazolidinedione derivatives and their use |
04/22/2003 | US6552056 Bactericides; fungicides; miticides; nematocides; for agriculture |
04/22/2003 | US6552054 Chromone derivatives, process for the preparation of the same and uses thereof |
04/22/2003 | US6552042 Anticoagulants |